New CEO and Headquarters Announced for UroDev Medical

UroDev Medical is starting off 2021 with a new leader and company headquarters.

The firm, formerly known as Spinal Singularity Inc., has appointed Matt Monarski as CEO and is now based in Minneapolis. 

“We have evolved significantly as a company and wanted to have a name that reflects this growth,” said Derek Herrera, founder and chief technology officer of UroDev Medical. “We believe the IntelliFlow System will not only help men suffering from urinary retention due to spinal injury, but all men experiencing the disruptive symptoms of this condition. I’m excited with the progress we’ve made as we approach our goal of bringing the product to the U.S. market. This is the perfect time to welcome Matt, a proven leader in bringing innovative solutions to the field of urology, as we prepare to become a commercial-stage company.”
 
Monarski joins the company with nearly 30 years of global commercial experience focused on advancing new urology, gynecology and orthopedic medical device technologies. Prior to joining UroDev Medical, Monarski held senior leadership positions at NeoTract | Teleflex, where he built the brand, led high-performance teams, cultivated worldwide key opinion leader networks, and spearheaded product launches and market development opportunities to successfully drive adoption of the company’s UroLift System. Prior to NeoTract | Teleflex, Monarski held a variety of marketing, sales and product management roles, most recently at American Medical Systems and Tornier.

Monarski earned a bachelor of arts degree and an MBA from the University of Saint Thomas.

“UroDev Medical is poised to successfully address a condition that affects millions of men in the U.S., and I couldn’t be more excited to join this team during this critical time in the company’s evolution,” said Monarski. “I believe in the potential of this disruptive technology to fill a growing clinical need in the urology space, and I look forward to leading the company through its next phase to submit for FDA clearance and prepare for commercialization.”
 
The name UroDev Medical reflects the company’s mission, embodied by its IntelliFlow Bladder Management System (formerly the Connected Catheter System), to improve the lives of those who wear permanent indwelling urinary catheters or live with intermittent catheterizations due to urinary retention. The new company name also conveys the company’s evolution as it looks to broaden its device use beyond spinal injury patients.
  
UroDev Medical has completed multiple clinical studies at sites across the U.S. and has initiated a pivotal clinical trial, the FREEDOM Study, to generate evidence in support of future regulatory submissions.
 
UroDev Medical is a medical device company dedicated to delivering products that improve the lives of people suffering from chronic urinary retention.